| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NAVIDEA BIOPHARMACEUTICALS, INC. | Chief Medical Officer | Common Stock | 55,725 | $4,904 | $0.0880 | 09 Sep 2022 | Direct |
| NAVIDEA BIOPHARMACEUTICALS, INC. | Chief Medical Officer | Common Stock | 11,320 | $996 | $0.0880 | 09 Sep 2022 | Held by 401(k) Plan |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NAVB | NAVIDEA BIOPHARMACEUTICALS, INC. | 09 Sep 2022 | 2 | $0 | 4 | Chief Medical Officer | 13 Sep 2022, 16:07 |
| NAVB | NAVIDEA BIOPHARMACEUTICALS, INC. | 14 Jan 2022 | 1 | $0 | 4 | Chief Medical Officer | 18 Jan 2022, 08:28 |
| NAVB | NAVIDEA BIOPHARMACEUTICALS, INC. | 27 Dec 2021 | 1 | +$100 | 4/A | Chief Medical Officer | 08 Mar 2022, 15:01 |